{"word_count": 87, "character_count": 602}
Auteur :  rédaction de BloombergProduction : The Japan TimesDiffusion : site de The Japan TimesDate : 21 mai 2020The lead researcher in the trial being conducted for the flu drug Avigan  said it’s too early to make a call on whether it works on COVID-19 and  patients are still being enrolled. Source : Bloomberg, « No pause in coronavirus trial for Avigan, Japan's lead researcher says », The Japan Times, 21/05/2020. URL : https://www.japantimes.co.jp/news/2020/05/21/business/coronavirus-trial-avigan/#.XsYwqMA69PY (consulté le 21/05/2020)Photo «&#160;à la une&#160;» : A tablet of Avigan © REUTERS 